Familial Hypercholesterolemia News and Research

RSS
Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Findings underscore importance of universal pediatric cholesterol screening

Findings underscore importance of universal pediatric cholesterol screening

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

Expert offers tips to help college students avoid serious health conditions down the road

Expert offers tips to help college students avoid serious health conditions down the road

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Investigational treatment for ALS passes early phase clinical trial for safety

Investigational treatment for ALS passes early phase clinical trial for safety

LDL apheresis can reduce cholesterol levels in patients with familial hypercholesterolemia

LDL apheresis can reduce cholesterol levels in patients with familial hypercholesterolemia

Genetic testing strategy for familial high cholesterol questioned

Genetic testing strategy for familial high cholesterol questioned

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

University of Cambridge forms new spin-out company to supply hIPSC-derived cells

University of Cambridge forms new spin-out company to supply hIPSC-derived cells

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

FDA accepts NDA filing for KYNAMRO to treat HoFH

FDA accepts NDA filing for KYNAMRO to treat HoFH

Positive results from Sanofi and Regeneron’s SAR236553/REGN727 Phase 2 trial on heFH

Positive results from Sanofi and Regeneron’s SAR236553/REGN727 Phase 2 trial on heFH

Experimental drugs from Sanofi and Regenron cut cholesterol in a new way

Experimental drugs from Sanofi and Regenron cut cholesterol in a new way

New cholesterol lowering drugs on the horizon

New cholesterol lowering drugs on the horizon